Intercept Pharmaceuticals (ICPT): News: $ICPT FDA Accepts Intercept's...

Featured News Placeholder

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the Internation...

NASDAQ:TLSA

Stock Options

NEW to INVESTORSHUB

Intercept Pharmaceuticals (ICPT)

Reply Private New

Next 10 Prev Next

Send PM

Followers	119
Posts	15138
Boards Moderated	2
Alias Born	06/04/2018

FREE
ICPT REPORT

Re: None

Monday, 11/25/2019 7:16:19 PM

Monday, November 25, 2019 7:16:19 PM

News: $ICPT FDA Accepts Intercept's NDA for OCA for the Treatment of Liver Fibrosis Due to NASH and Grants Priority Review

NEW YORK, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that the U.S. Food and Drug Administra...

Read the whole news ICPT - FDA Accepts Intercept's NDA for OCA for the Treatment of Liver Fibrosis Due to NASH and Grants Priority Review

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ICPT News

Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/23/2023 08:02:16 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/16/2023 08:08:17 PM
Intercept Says FDA Sets AdCom Meeting on Obeticholic Acid • Dow Jones News • 03/10/2023 03:05:00 PM
Intercept Announces FDA Advisory Committee Meeting Date for Obeticholic Acid as a Treatment for Pre-Cirrhotic Liver Fibrosis due to NASH • GlobeNewswire Inc. • 03/10/2023 02:05:00 PM
Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Barclays Global Healthcare Conference March 14, 2023 • GlobeNewswire Inc. • 03/09/2023 01:00:00 PM
Annual Report (10-k) • Edgar (US Regulatory) • 03/02/2023 09:33:43 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/02/2023 12:06:06 PM
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates; Issues 2023 Financial Guidance • GlobeNewswire Inc. • 03/02/2023 12:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/27/2023 01:01:09 PM
Intercept Pharmaceuticals to Participate in Cowen’s 43rd Annual Health Care Conference on March 7, 2023 • GlobeNewswire Inc. • 02/27/2023 01:00:00 PM
Intercept to Announce Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 • GlobeNewswire Inc. • 02/23/2023 01:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/21/2023 01:01:29 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/16/2023 09:03:54 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:03:34 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:49:43 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/03/2023 09:02:33 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/02/2023 05:26:01 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:05:33 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:05:13 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:04:43 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:04:15 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 01/31/2023 06:59:42 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/25/2023 01:01:38 PM
FDA Accepts Intercept’s New Drug Application for OCA for the Treatment of Pre-Cirrhotic Liver Fibrosis Due to NASH • GlobeNewswire Inc. • 01/19/2023 01:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/17/2023 01:01:39 PM

More ICPT News

InvestorsHub NewsWire

FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!